References
1. MIYAKIS S, LOCKSHIN MD, ATSUMI T, BRANCH DW, BREY RL, CERVERA R, et
al. International consensus statement on an update of the classification
criteria for definite antiphospholipid syndrome (APS).
2006;4(2):295-306.
2. Hughes GR, Khamashta MA. Seronegative antiphospholipid syndrome.
Annals of the rheumatic diseases. 2003;62(12):1127.
3. Pignatelli P, Ettorre E, Menichelli D, Pani A, Violi F, Pastori D.
Seronegative antiphospholipid syndrome: refining the value of
”non-criteria” antibodies for diagnosis and clinical management.
Haematologica. 2020;105(3):562-72.
4. Devreese KM, Pierangeli SS, de Laat B, Tripodi A, Atsumi T, Ortel TL.
Testing for antiphospholipid antibodies with solid phase assays:
guidance from the SSC of the ISTH. Journal of thrombosis and haemostasis
: JTH. 2014;12(5):792-5.
5. Volkov I, Seguro L, Leon EP, Kovács L, Roggenbuck D, Schierack P, et
al. Profiles of criteria and non-criteria anti-phospholipid
autoantibodies are associated with clinical phenotypes of the
antiphospholipid syndrome. Auto- immunity highlights. 2020;11(1):8.
6. Litvinova E, Darnige L, Kirilovsky A, Burnel Y, de Luna G,
Dragon-Durey MA. Prevalence and Significance of Non-conventional
Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
Frontiers in immunology. 2018;9:2971.
7. Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB,
Forastiero R, et al. 14th International Congress on Antiphospholipid
Antibodies Task Force. Report on antiphospholipid syndrome laboratory
diagnostics and trends. Autoimmunity reviews. 2014;13(9):917-30.
8. Lakos G, Favaloro EJ, Harris EN, Meroni PL, Tincani A, Wong RC, et
al. International consensus guidelines on anticardiolipin and
anti-β2-glycoprotein I testing: report from the 13th International
Congress on Antiphospholipid Antibodies. Arthritis Rheum.
2012;64(1):1-10.
9. Iaccarino L, Ghirardello A, Canova M, Zen M, Bettio S, Nalotto L, et
al. Anti-annexins autoantibodies: their role as biomarkers of autoimmune
diseases. Autoimmunity reviews. 2011;10(9):553-8.
10. Andree HA, Stuart MC, Hermens WT, Reutelingsperger CP, Hemker HC,
Frederik PM, et al. Clustering of lipid-bound annexin V may explain its
anticoagulant effect. The Journal of biological chemistry.
1992;267(25):17907-12.
11. Rodríguez-García V, Ioannou Y, Fernández-Nebro A, Isenberg DA, Giles
IP. Examining the prevalence of non-criteria anti-phospholipid
antibodies in patients with anti-phospholipid syndrome: a systematic
review. Rheumatology (Oxford, England). 2015;54(11):2042-50.
12. Singh NK, Yadav DP, Gupta A, Singh U, Godara M. Role of anti-annexin
A5 in pathogenesis of hypercoagulable state in patients with
antiphospholipid syndrome. International journal of rheumatic diseases.
2013;16(3):325-30.
13. de Laat B, Derksen RH, Mackie IJ, Roest M, Schoormans S, Woodhams
BJ, et al. Annexin A5 polymorphism (-1C–>T) and the
presence of anti-annexin A5 antibodies in the antiphospholipid syndrome.
Annals of the rheumatic diseases. 2006;65(11):1468-72.
14. Rand JH, Wu XX, Lapinski R, van Heerde WL, Reutelingsperger CP, Chen
PP, et al. Detection of antibody-mediated reduction of annexin A5
anticoagulant activity in plasmas of patients with the antiphospholipid
syndrome. Blood. 2004;104(9):2783-90.
15. Ueki H, Mizushina T, Laoharatchatathanin T, Terashima R, Nishimura
Y, Rieanrakwong D, et al. Loss of maternal annexin A5 increases the
likelihood of placental platelet thrombosis and foetal loss. Scientific
reports. 2012;2:827.
16. Ogawa H, Zhao D, Dlott JS, Cameron GS, Yamazaki M, Hata T, et al.
Elevated anti-annexin V antibody levels in antiphospholipid syndrome and
their involvement in antiphospholipid antibody specificities. American
journal of clinical pathology. 2000;114(4):619-28.
17. Arnold J, Holmes Z, Pickering W, Farmer C, Regan L, Cohen H.
Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with
recurrent miscarriage. British journal of haematology.
2001;113(4):911-4.
18. Amengual O, Forastiero R, Sugiura-Ogasawara M, Otomo K, Oku K, Favas
C, et al. Evaluation of phosphatidylserine-dependent antiprothrombin
antibody testing for the diagnosis of antiphospholipid syndrome: results
of an international multicentre study. Lupus. 2017;26(3):266-76.
19. Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA,
Bertolaccini ML. Anti-prothrombin (aPT) and
anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of
thrombosis in the antiphospholipid syndrome. A systematic review.
Thrombosis and haemostasis. 2014;111(2):354-64.
20. Devreese KMJ, Ortel TL, Pengo V, de Laat B. Laboratory criteria for
antiphospholipid syndrome: communication from the SSC of the ISTH.
Journal of thrombosis and haemostasis : JTH. 2018;16(4):809-13.
21. Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura
E, et al. Association of autoantibodies against the
phosphatidylserine-prothrombin complex with manifestations of the
antiphospholipid syndrome and with the presence of lupus anticoagulant.
Arthritis Rheum. 2000;43(9):1982-93.
22. Sciascia S, Radin M, Cecchi I, Rubini E, Scotta A, Rolla R, et al.
Reliability of Lupus Anticoagulant and
Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid
Syndrome: A Multicenter Study. Frontiers in immunology. 2019;10:376.
23. Pengo V, Ruffatti A, Legnani C, Testa S, Fierro T, Marongiu F, et
al. Incidence of a first thromboembolic event in asymptomatic carriers
of high-risk antiphospholipid antibody profile: a multicenter
prospective study. Blood. 2011;118(17):4714-8.
24. Zhang S, Wu Z, Li J, Wen X, Li L, Zhang W, et al. Evaluation of the
clinical relevance of anti-annexin-A5 antibodies in Chinese patients
with antiphospholipid syndrome. Clinical rheumatology.
2017;36(2):407-12.
25. Shi H, Zheng H, Yin YF, Hu QY, Teng JL, Sun Y, et al.
Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential
diagnostic markers and risk predictors of venous thrombosis and
obstetric complications in antiphospholipid syndrome. Clinical chemistry
and laboratory medicine. 2018;56(4):614-24.
26. Zhu L, Li C, Liu N, Yang X, Jia RL, Mu R, et al. Diagnostic value of
antibodies to phosphatidylserine/prothrombin complex for
antiphospholipid syndrome in Chinese patients. Clinical rheumatology.
2017;36(2):401-6.
27. Liu T, Gu J, Wan L, Hu Q, Teng J, Liu H, et al. ”Non-criteria”
antiphospholipid antibodies add value to antiphospholipid syndrome
diagnoses in a large Chinese cohort. Arthritis research & therapy.
2020;22(1):33.
28. Hu C, Li X, Zhao J, Wang Q, Li M, Tian X, et al. Immunoglobulin A
Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for
the Diagnosis of Antiphospholipid Syndrome in a Chinese Population.
Frontiers in immunology. 2020;11:568503.
29. Paule R, Morel N, Le Guern V, Fredi M, Coutte L, Belhocine M, et al.
Classification of primary antiphospholipid syndrome as systemic lupus
erythematosus: Analysis of a cohort of 214 patients. Autoimmunity
reviews. 2018;17(9):866-72.
30. Vlagea A, Gil A, Cuesta MV, Arribas F, Diez J, Lavilla P, et al.
Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential
markers of antiphospholipid syndrome. Clinical and applied
thrombosis/hemostasis : official journal of the International Academy of
Clinical and Applied Thrombosis/Hemostasis. 2013;19(3):289-96.
31. Žigon P, Perdan Pirkmajer K, Tomšič M, Kveder T, Božič B, Sodin
Šemrl S, et al. Anti-Phosphatidylserine/Prothrombin Antibodies Are
Associated with Adverse Pregnancy Outcomes. Journal of immunology
research. 2015;2015:975704.
32. Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, Ramire de Jesus
G, Erkan D. Estimated frequency of antiphospholipid antibodies in
patients with pregnancy morbidity, stroke, myocardial infarction, and
deep vein thrombosis: a critical review of the literature. Arthritis
care & research. 2013;65(11):1869-73.
33. Devreese KMJ. How to Interpret Antiphospholipid Laboratory Tests.
Current rheumatology reports. 2020;22(8):38.